M
Michael S. Broder
Researcher at University of California, Los Angeles
Publications - 213
Citations - 9650
Michael S. Broder is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Health care & Population. The author has an hindex of 37, co-authored 197 publications receiving 8291 citations. Previous affiliations of Michael S. Broder include American Academy of Allergy, Asthma and Immunology & University of Auckland.
Papers
More filters
Journal ArticleDOI
Tolerability of central nervous system symptoms among HIV-1 infected efavirenz users: analysis of patient electronic medical record data.
Lisa Rosenblatt,Michael S. Broder,Tanya G K Bentley,Eunice Chang,Sheila R. Reddy,Elya Papoyan,Joel Myers +6 more
TL;DR: This retrospective cohort study used a nationally representative electronic medical records database to identify HIV-1 patients ≥12 years old and found that EFV discontinuation due to CNS symptoms was low, consistent with prior reports.
Journal ArticleDOI
Consensus treatment guidelines for urgent symptoms in cholangiocarcinoma (CC) patients (pts) with biliary stents or catheters using the modified RAND/UCLA Delphi process.
Renuka Iyer,Susan Acquisto,John Bridgewater,Michael A. Choti,Theodore S. Hong,Bela Kis,Peter A. Mead,Neehar D. Parikh,Lewis R. Roberts,Rebecca Roberts,Jason K. Sicklick,Richard S. Siegel,Jonathan Whisenant,Dasha Cherepanov,Michael S. Broder,Juan W. Valle +15 more
TL;DR: An expert panel consensus is developed using the modified RAND/UCLA Delphi process to rate treatment appropriateness in CC pts with biliary stents or catheters with fever and/or jaundice for which there is no uniform guideline.
Journal ArticleDOI
Health care utilization and costs in patients with early onset myelodysplastic syndrome in a commercially insured population.
TL;DR: In this study, few patients aged ≥ 65 and newly diagnosed MDS were treated with HMA or TA in the first year after diagnosis, despite the fact that the HMAs have been shown to lead to improvement in clinical and economic outcomes and are recommended in the NCCN guidelines.
Journal ArticleDOI
Corticosteroid-Related Adverse Events in Chronic Idiopathic Urticaria
Dennis K. Ledford,Michael S. Broder,Evgeniya Antonova,Paul G. Solari,Theodore A. Omachi,Eunice Chang,Gordon H. Sun +6 more
TL;DR: The main outcome of interest was the risk of developing a new instance of a possible AE.
Journal ArticleDOI
The use of real-world data to examine comparative effectiveness research (CER) and treatment patterns in HER2-negative and triple-negative metastatic breast cancer (MBC): A systematic literature review.
TL;DR: Common endpoints reported in RWD studies on CER and TxP in MBC, focusing on HER2-negative and Triple Negative MBC are examined, finding increased studies using RWD increased over time with 2 studies published over time.